WebJan 3, 2024 · According to the FACED score we found 20 patients (50%) with mild BC, 15 patients (37.5%) with moderate and 5 patients (12.5%) with severe BC. WebMay 11, 2024 · The FACED score predicted all-cause and respiratory mortality with an 81% and 82% accuracy, respectively. It also helped divide patients into three groups according to disease mortality: mild, 3.7%; …

FACED Score - Bronchiectasis

WebMean FACED and E-FACED scores were 2.36±1.8 and 3.02±2.23, respectively. According to the FACED and E-FACED scores, 56.6% and 61.5% of patients presented mild bronchiectasis; 29.5% and 30% moderate bronchiectasis and 13.8% and 8.6% severe bronchiectasis, respectively. The cumulative mortality was as follows. WebThe total score predicted the 5-year all-cause mortality in the validation data with an area under a receiver-operating characteristic curve (AUC) of 0.83. To provide clinical context, this equates to a 5-year mortality in mild, moderate and severe disease (defined as a score of 0–2, 3–4 and 5–7, respectively) of 4%, 25% and 56%, respectively. la gresca san sebastian

Bronchiectasis Prediction Tools Predicting Mortality and …

WebThe bronchiectasis severity index (BSI) and FACED score are currently used in predicting outcomes of non-cystic fibrosis bronchiectasis (NCFB). Distance-saturation product (DSP), the product of distance walked, and lowest oxygen saturation during the 6-min walk test showed strong predictive power of mortality in non-CF bronchiectasis patients. http://www.bronchiectasisseverity.com/ WebThe severity of bronchiectasis was mild (score≤ 2) for 52.5% (n=43), Moderate (score= 3-4) for 36.6% (n=30) and Severe (score ≥5) for 10.9% (n=9) of the study participants … jed montayre